Federal procurement of antineoplastic drugs in Brazil: analysis of imatinib mesylate, trastuzumab and L-asparaginase, 2004-2013

Conclusions: The setting of Productive Development Partnerships (PDPs) and centralized purchasing by the Brazilian Ministry of Health suggest a decrease in prices for imatinib and trastuzumab, underlining the government ´s purchasing power. These reductions may contribute to availability of these medicines in the Brazilian Public Health System.
Source: Physis: Revista de Saude Coletiva - Category: Global & Universal Source Type: research